Please select an option below to help us tailor your newsletter to best suit your content interests!
Abstract The phosphatidylinositol-3-kinase (PI3K) pathway is frequently dysregulated in human breast cancer. Approximately 30%of all patients with breast cancer will carry mutations of the PIK3CA gene, which encodes the PI3K catalytic subunit isoform p110a. Mutations in PIK3CA have been associated with resistance to endocrine therapy, HER2-directed therapy, and cytotoxic therapy. Early trials of pan-PI3K inhibitors… Read more »
“We really believe that biosimilars line up as a value accretion for every constituency, whether it’s the patient, the practice, or the payer,” said Lee Schwartzberg, MD, FACP, executive director, West Cancer Center. Click here for full article & video interview. Transcript: OneOncology announced that its practices have begun administering the 2 cancer… Read more »
In 2016, I was diagnosed with Stage 1 breast cancer. And I was, on one level, lucky. Lucky that, after not bothering to get a mammogram since 2011, I didn’t discover a tumor that had spread to other parts of my body. “After four years of not being screened, that is a blessing,” said Keesha… Read more »
West Cancer Center – Methodist Le Bonheur Healthcare Would like to invite you to attend Thriving Together: Living Beyond Metastatic Breast Cancer! Monday, July 31, 2017, 6 p.m. – 8 p.m West Cancer Center 7945 Wolf River Blvd Germantown, TN 38138 Our Keynote Speaker & Program will begin at 7:15 p.m. on… Read more »
West Cancer Center and the Ovarian Cancer Awareness Foundation announced today a fundraising partnership teaming the annual Ovarian Cancer Awareness 5K Teal Run and Walk to join in the West Fight On Cycle, Run, Walk event on September 17 at Shelby Farms Park. “We are looking forward to joining forces with West Cancer Center and… Read more »